Trademark Overview
On Thursday, November 13, 2025, a trademark application was filed for SEQUENCIO with the United States Patent and Trademark Office. The USPTO has given the SEQUENCIO trademark a serial number of 99494302. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 13, 2025. This trademark is owned by Sequencio Therapeutics Company Limited. The SEQUENCIO trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for treatment of cancer; human vaccine preparations; anti-cancer preparations; anti-cancer agents; drugs for the treatment of cancer; drugs for medical purposes; medicines for human purposes; vaccines against cancer; anti-cancer drugs; therapeutic cancer vaccines; immunotherapeutic agent; biological preparations for the treatment of premalignant disease to prevent malignant transformation; biological preparations for the treatment of premalignant conditions